These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 31789594)

  • 1. Herpesviral lytic gene functions render the viral genome susceptible to novel editing by CRISPR/Cas9.
    Oh HS; Neuhausser WM; Eggan P; Angelova M; Kirchner R; Eggan KC; Knipe DM
    Elife; 2019 Dec; 8():. PubMed ID: 31789594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas9 system-driven site-specific selection pressure on Herpes simplex virus genomes.
    Li Z; Bi Y; Xiao H; Sun L; Ren Y; Li Y; Chen C; Cun W
    Virus Res; 2018 Jan; 244():286-295. PubMed ID: 28279800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A knockdown of the herpes simplex virus type-1 gene in all-in-one CRISPR vectors.
    Khodadad N; Fani M; Jamehdor S; Nahidsamiei R; Makvandi M; Kaboli S; Teimoori A; Thekkiniath J
    Folia Histochem Cytobiol; 2020; 58(3):174-181. PubMed ID: 32937678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA-guided gene editing of the murine gammaherpesvirus 68 genome reduces infectious virus production.
    Foreman HC; Kirillov V; Paniccia G; Catalano D; Andrunik T; Gupta S; Krug LT; Zhang Y
    PLoS One; 2021; 16(6):e0252313. PubMed ID: 34086743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections.
    van Diemen FR; Kruse EM; Hooykaas MJ; Bruggeling CE; Schürch AC; van Ham PM; Imhof SM; Nijhuis M; Wiertz EJ; Lebbink RJ
    PLoS Pathog; 2016 Jun; 12(6):e1005701. PubMed ID: 27362483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HSV-1 Replication by Gene Editing Strategy.
    Roehm PC; Shekarabi M; Wollebo HS; Bellizzi A; He L; Salkind J; Khalili K
    Sci Rep; 2016 Apr; 6():23146. PubMed ID: 27064617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting human cytomegalovirus IE genes by CRISPR/Cas9 nuclease effectively inhibits viral replication and reactivation.
    Xiao J; Deng J; Zhang Q; Ma P; Lv L; Zhang Y; Li C; Zhang Y
    Arch Virol; 2020 Aug; 165(8):1827-1835. PubMed ID: 32507978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9 Inhibits Multiple Steps of HIV-1 Infection.
    Yin L; Hu S; Mei S; Sun H; Xu F; Li J; Zhu W; Liu X; Zhao F; Zhang D; Cen S; Liang C; Guo F
    Hum Gene Ther; 2018 Nov; 29(11):1264-1276. PubMed ID: 29644868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Employs Multiple Mechanisms To Resist Cas9/Single Guide RNA Targeting the Viral Primer Binding Site.
    Wang Z; Wang W; Cui YC; Pan Q; Zhu W; Gendron P; Guo F; Cen S; Witcher M; Liang C
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting NECTIN-1 Based on CRISPR/Cas9 System Attenuated the Herpes Simplex Virus Infection in Human Corneal Epithelial Cells In Vitro.
    Li Y; Wei Y; Li G; Huang S; Xu J; Ding Q; Hong J
    Transl Vis Sci Technol; 2022 Feb; 11(2):8. PubMed ID: 35119473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9-Based Genome Editing of Transcription Factor Genes in Marchantia polymorpha.
    Sugano SS; Nishihama R
    Methods Mol Biol; 2018; 1830():109-126. PubMed ID: 30043367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Genome Editing Approaches against Herpes Simplex Virus Infections.
    Zhang I; Hsiao Z; Liu F
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33671590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing the Efficiency of CRISPR/Cas9-mediated Precise Genome Editing of HSV-1 Virus in Human Cells.
    Lin C; Li H; Hao M; Xiong D; Luo Y; Huang C; Yuan Q; Zhang J; Xia N
    Sci Rep; 2016 Oct; 6():34531. PubMed ID: 27713537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mismatch Intolerance of 5'-Truncated sgRNAs in CRISPR/Cas9 Enables Efficient Microbial Single-Base Genome Editing.
    Lee HJ; Kim HJ; Lee SJ
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Application of the CRISPR/Cas9 System against Herpesvirus Infections.
    Chen YC; Sheng J; Trang P; Liu F
    Viruses; 2018 May; 10(6):. PubMed ID: 29844277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-Color CRISPR Imaging Reveals Dynamics of Herpes Simplex Virus 1 Replication Compartments and Virus-Host Interactions.
    Xu H; Wang J; Deng Y; Hou F; Fu Y; Chen S; Zou W; Pan D; Chen B
    J Virol; 2022 Dec; 96(24):e0092022. PubMed ID: 36453882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete and Prolonged Inhibition of Herpes Simplex Virus Type 1 Infection In Vitro by CRISPR/Cas9 and CRISPR/CasX Systems.
    Karpov DS; Demidova NA; Kulagin KA; Shuvalova AI; Kovalev MA; Simonov RA; Karpov VL; Snezhkina AV; Kudryavtseva AV; Klimova RR; Kushch AA
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9-Mediated Genome Editing of Trichoderma reesei.
    Zou G; Zhou Z
    Methods Mol Biol; 2021; 2234():87-98. PubMed ID: 33165782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential and challenges of CRISPR-Cas in eradication of hepatitis B virus covalently closed circular DNA.
    Yang HC; Chen PJ
    Virus Res; 2018 Jan; 244():304-310. PubMed ID: 28627393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing.
    Graf R; Li X; Chu VT; Rajewsky K
    Cell Rep; 2019 Jan; 26(5):1098-1103.e3. PubMed ID: 30699341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.